⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1865106 | 0.76 | — | — | |
| SCHEMBL1259564 | 0.73 | — | — | |
| SCHEMBL4286663 | 0.71 | HPGDS (0.30) | — | |
| SCHEMBL1047666 | 0.67 | — | — | |
| SCHEMBL1047665 | 0.67 | — | — | |
| SCHEMBL9608311 | 0.67 | — | — | |
| SCHEMBL24641068 | 0.64 | — | — | |
| SCHEMBL29875445 | 0.64 | — | — | |
| SCHEMBL17926752 | 0.63 | — | — | |
| SCHEMBL1459930 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1993024485-A1 | OXAZOLE DERIVATIVES AND THEIR USE AS ANTIULCER AGENTS AND H2-RECEPTOR ANTAGONIST | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-12-09 | — | — | WO | disclosed |